Loading...
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
An unresolved issue in chronic lymphocytic leukemia (CLL) is whether IGHV3-21 gene usage, in general, or the expression of stereotyped B-cell receptor immunoglobulin defining subset #2 (IGHV3-21/IGLV3-21), in particular, determines outcome for IGHV3-21-utilizing cases. We reappraised this issue in 8...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311230/ https://ncbi.nlm.nih.gov/pubmed/25634617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-09-600874 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|